Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals
- PMID: 26909131
- PMCID: PMC4753167
- DOI: 10.4251/wjgo.v8.i2.165
Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals
Abstract
Pancreatic cancer (PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition, radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.
Keywords: Diagnosis; Pancreatic cancer; Positron emission tomography; Radiopharmaceuticals; Therapy.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
